Answers are grounded in this paper and cite their sources.
Mechanistic review reveals how AMPK regulates fat storage and glucose uptake in white adipose tissue, suggesting safe therapeutic avenues for treating type 2 diabetes.
White adipose tissue (WAT) plays an important role in the integration of whole-body metabolism by storing fat and mobilizing triacylglycerol when needed. The released free fatty acids can then be oxidized by other tissues to provide ATP. AMP-activated protein kinase (AMPK) is a key regulator of metabolic pathways, and can be targeted by a new generation of direct, small-molecule activators. AMPK activation in WAT inhibits insulin-stimulated lipogenesis and in some situations also inhibits insulin-stimulated glucose uptake, but AMPK-induced inhibition of β-adrenergic agonist-stimulated lipolysis might need to be re-evaluated in vivo. The lack of dramatic effects of AMPK activation on basal metabolism in WAT could be advantageous when treating type 2 diabetes with pharmacological pan-AMPK activators.
No takes yet. Share an insight, caveat, or question.
Göransson et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: